All Stories

  1. Change in practice in gynecologic oncology during the COVID-19 pandemic: a social media survey
  2. The role of Hysteroscopy in endometrial cancer sentinel node mapping
  3. Corrigendum to “Advances in laparoscopic surgery for cervical cancer” [Crit. Rev. Oncol. Hematol. 143 (August) (2019) 76–80]
  4. Advances in laparoscopic surgery for cervical cancer
  5. Re: Concordance Between Intracervical and Fundal Injections for Sentinel Node Mapping in Patients With Endometrial Cancer? A Study Using Intracervical Radiotracer and Fundal Blue Dye Injections
  6. Nomogram-based prediction of cervical dysplasia persistence/recurrence
  7. Burden of lymphatic disease predicts efficacy of adjuvant radiation and chemotherapy in FIGO 2018 stage IIICp cervical cancer
  8. Long-term results of fertility-sparing treatment for early-stage cervical cancer
  9. Oncological outcome of surgical management in patients with recurrent uterine cancer—a multicenter retrospective cohort study—CEEGOG EX01 Trial
  10. Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence
  11. Predictive factors of recurrence in patients with early‐stage epithelial ovarian cancer
  12. Minimally invasive surgery improves short-term outcomes of nerve-sparing radical hysterectomy in patients with cervical cancer: a propensity-matched analysis with open abdominal surgery
  13. Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective study
  14. Fertility preservation in women with malignancies: the accuracy of antral follicle count collected randomly during the menstrual cycle in predicting the number of oocytes retrieved
  15. Investigating the Role of Minimally Invasive Radical Hysterectomy in Cervical Cancer
  16. Rectus Abdominis Myofascial Flap for Vaginal Reconstruction After Pelvic Exenteration
  17. Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC–IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional Study
  18. New prophylactics human papilloma virus (HPV) vaccines against cervical cancer
  19. Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence
  20. The addition of lymphadenectomy to secondary cytoreductive surgery in comparison with bulky node resection in patients with recurrent ovarian cancer
  21. Neoadjuvant chemotherapy followed by interval debulking surgery for unresectable stage IVB Serous endometrial cancer
  22. Potential impact of introducing a nonavalent HPV vaccination
  23. Factors Predictive of 90-Day Morbidity, Readmission, and Costs in Patients Undergoing Pelvic Exenteration
  24. Role of bevacizumab in uterine leiomyosarcoma
  25. LASER treatment for women with high-grade vaginal intraepithelial neoplasia: A propensity-matched analysis on the efficacy of ablative versus excisional procedures
  26. Predicting Factors for High-Grade Cervical Dysplasia in Women With Low-Grade Cervical Cytology and Nonvisible Squamocolumnar Junction
  27. The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment
  28. A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
  29. Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
  30. Oncologic effectiveness of nerve-sparing radical hysterectomy in cervical cancer
  31. The detrimental effect of adopting interval debulking surgery in advanced stage low-grade serous ovarian cancer
  32. Locally Advanced Cervical Cancer: Is a Trimodality Treatment a Safe and Effective Approach?
  33. Nerve-Sparing Approach Improves Outcomes of Patients Undergoing Minimally Invasive Radical Hysterectomy: A Systematic Review and Meta-Analysis
  34. Fertility preservation in women harboring deleterious BRCA mutations: ready for prime time?
  35. Regarding “The Role of Routine Peritoneal and Omental Biopsies at Risk-reducing Salpingo-oophorectomy”
  36. Introducing nerve-sparing approach during minimally invasive radical hysterectomy for locally-advanced cervical cancer: A multi-institutional experience
  37. The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC–IV Unresectable Ovarian Cancer
  38. Invasive Paget Disease of the Vulva
  39. Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses
  40. Lymphnode evaluation with SLN procedure after peritumoral injection of tracer with hysteroscopy
  41. Safety and effectiveness of Human Papillomavirus (HPV) vaccination: NCI of Milan position statement
  42. Implementation of Extensive Cytoreduction Resulted in Improved Survival Outcomes for Patients with Newly Diagnosed Advanced-Stage Ovarian, Tubal, and Peritoneal Cancers
  43. Selecting patients for Laparoscopic interval debulking surgey (IDS) in ovarian cancer
  44. Interpregnancy Interval and Adverse Pregnancy Outcomes
  45. Treatment of Genital Melanoma
  46. Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience
  47. Impact of Surgical Route in Influencing the Risk of Lymphatic Complications After Ovarian Cancer Staging
  48. The safety of antiangiogenic agents and PARP inhibitors in platinum-sensitive recurrent ovarian cancer
  49. Long-acting recombinant follicle-stimulating hormone in random-start ovarian stimulation protocols for fertility preservation in women with cancer
  50. Minimally Invasive Surgical Staging in Early-stage Ovarian Carcinoma: A Systematic Review and Meta-analysis
  51. Sentinel-lymph-node mapping in endometrial cancer
  52. Retrospective study of the influence of HPV persistence on outcomes among women with high-risk HPV infections and negative cytology
  53. The association of pre-treatment HPV subtypes with recurrence of VIN
  54. Human papillomavirus (HPV) persistence and HPV 31 predict the risk of recurrence in high-grade vaginal intraepithelial neoplasia
  55. Accuracy of pre-operative hysteroscopic guided biopsy for predicting final pathology in uterine malignancies
  56. Impact of Blood Transfusions on Survival of Locally Advanced Cervical Cancer Patients Undergoing Neoadjuvant Chemotherapy Plus Radical Surgery
  57. Type-specific HPV infection correlates with risk of recurrence of vulvar intraepithelial neoplasia usual type
  58. Sentinel node techinique in endometrial cancer
  59. Chemotherapy-related leukopenia as a biomarker predicting survival outcomes in locally advanced cervical cancer
  60. Minimally Invasive Surgical Staging for Ovarian Carcinoma: A Propensity-Matched Comparison With Traditional Open Surgery
  61. Bulky Mesonephric Adenocarcinoma of the Uterine Cervix Treated with Neoadjuvant Chemotherapy and Radical Surgery: Report of the First Case
  62. Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: A systematic review and meta-analysis
  63. 16th Biennial Meeting of the International Gynecologic Cancer Society
  64. Fertility preservation in women with borderline ovarian tumours
  65. Surgical Management and Prognostic Factors of Vulvovaginal Melanoma
  66. Incorporating 3D Laparoscopy for the Management of Locally Advanced Cervical Cancer: A Comparison with Open Surgery
  67. Is aortic lymphadenectomy indicated in locally advanced cervical cancer after neoadjuvant chemotherapy followed by radical surgery? A retrospective study on 261 women
  68. Morcellator's Port-site Metastasis of a Uterine Smooth Muscle Tumor of Uncertain Malignant Potential After Minimally Invasive Myomectomy
  69. Extraperitoneal Robotic-Assisted Para-Aortic Lymphadenectomy in Gynecologic Cancer Staging: Current Evidence
  70. 3D Vision Improves Outcomes in Early Cervical Cancer Treated with Laparoscopic Type B Radical Hysterectomy and Pelvic Lymphadenectomy
  71. Surgical Techniques for Diaphragmatic Resection During Cytoreduction in Advanced or Recurrent Ovarian Carcinoma
  72. Morcellation of undiagnosed uterine sarcoma: A critical review
  73. FDG-PET/CT to Predict Optimal Primary Cytoreductive Surgery in Patients with Advanced Ovarian Cancer: Preliminary Results
  74. Adult-Onset Cervical Embryonal Rhabdomyosarcoma and DICER1 Mutations
  75. Reply to A Buda
  76. Don't forget the uterus while preserving fertility
  77. Morcellation of apparent benign uterine myoma: assessing risk to benefit ratio
  78. Fertility Sparing Options in Gynecologic Oncology
  79. Abstract B157: OX40 expression in tumor-associated Tregs as a potential prognostic biomarker and immunotherapeutic target in ovarian cancer
  80. Pneumoperitoneum pressures during pelvic laparoscopic surgery: a systematic review and meta-analysis
  81. Incidence of port-site hernia following robotic-assisted sacrocolpopexy
  82. Sentinel Node Mapping in Endometrial Cancer By Using Hysteroscopic Injection of Indocyanine Green and Laparoscopic Near-Infrared Fluorescence Imaging: A Preliminary Experience
  83. OC07.05: Application of 3D ultrasound in the assessment of dose-dense NACT efficacy in patients with cervical cancer
  84. When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer
  85. Time for a less radical surgery in cervical cancer after neoadjuvant chemotherapy?
  86. Peritoneal cytology as prognostic factor in cervical cancer
  87. Long-term safety of fertility sparing surgery in early stage ovarian cancer: Comparison to standard radical surgical procedures
  88. Surgical Treatment of Recurrent Endometrial Cancer: Time for a Paradigm Shift
  89. Fertility-Sparing Surgery in Early-Stage Cervical Cancer Patients
  90. Sentinel Node Mapping Using Hysteroscopic Injection of Indocyanine Green and Laparoscopic Near-Infrared Fluorescence Imaging in Endometrial Cancer Staging
  91. Implementation of laparoscopic approach for type B radical hysterectomy: A comparison with open surgical operations
  92. Treatment of Early Ovarian Cancer
  93. A critical assessment on the role of sentinel node mapping in endometrial cancer
  94. Fertility-sparing surgery in high-risk ovarian cancer
  95. Carboplatin-Paclitaxel Versus Cisplatin-Ifosfamide in the Treatment of Uterine Carcinosarcoma
  96. Risk of thrombosis in women with malignancies undergoing ovarian stimulation for fertility preservation
  97. Class II versus Class III radical hysterectomy in early cervical cancer: An observational study in a tertiary center
  98. Phase II prospective study on trabectedin (T) in BRCA-mutated and BRCAness phenotype advanced ovarian cancer (AOC) patients (pts): The MITO 15 trial.
  99. Fertility sparing surgery in early stage epithelial ovarian cancer
  100. Role of paclitaxel and cisplatin as the neoadjuvant treatment for locally advanced squamous cell carcinoma of the vulva
  101. Embryonal Rhabdomyosarcoma of the Uterine Cervix in Adults
  102. Radical Abdominal Hysterectomy Type B
  103. Photodynamic therapy with M-ALA as non surgical treatment option in patients with primary extramammary Paget's disease
  104. The Role of Lymphadenectomy in Cervical Cancer Patients: The Significance of the Number and the Status of Lymph Nodes Removed in 526 Cases Treated in a Single Institution
  105. Advanced ovarian cancer: Omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor
  106. Laparoscopic Versus Open Radical Hysterectomy for Stage IB2–IIB Cervical Cancer in the Setting of Neoadjuvant Chemotherapy: A Multi-institutional Cohort Study
  107. Utility of Conization With Frozen Section for Intraoperative Triage Prior to Definitive Hysterectomy
  108. Frozen cone to decide between simple or radical hysterectomy
  109. Diagnostic accuracy of sentinel node in endometrial cancer by using hysteroscopic injection of radiolabeled tracer
  110. Systematic Para-aortic and Pelvic Lymphadenectomy in Early Stage Epithelial Ovarian Cancer: A Prospective Study
  111. Third-line chemotherapy with tyrosine kinase inhibitor (imatinib mesylate) in recurrent ovarian granulosa cell tumor: Case report
  112. Class III Nerve-sparing Radical Hysterectomy Versus Standard Class III Radical Hysterectomy: An Observational Study
  113. Class III NSRH: Oncological outcome in 170 cervical cancer patients
  114. Sentinel Node Detection in Endometrial Cancer. Diagnostic Accuracy Evaluation
  115. Quality of Life and Sexual, Bladder, and Intestinal Dysfunctions After Class III Nerve-Sparing and Class II Radical Hysterectomies
  116. Nerve-Sparing Radical Vaginectomy
  117. Weekly topotecan and cisplatin (TOPOCIS) as neoajuvant chemotherapy for locally-advanced squamous cervical carcinoma: results of a phase II study
  118. Hysteroscopy in endometrial cancer: new methods to evaluate transtubal leakage of saline distension medium
  119. Nerve-sparing radical hysterectomy in cervical cancer: Evolution of concepts
  120. Incidental Diagnosis of Primary Vaginal Adenocarcinoma of Intestinal Type
  121. Surgical Treatment in FIGO Stage I Cervical Cancer: Evolution of Concepts
  122. Angiokeratoma corporis diffusum (Anderson-Fabry's disease): a case report